Concepedia

Feng Wang

FW

Statistics

Publications

15

Citations

1.7K

H-Index

15

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Hirosaki University

The University of Texas Health Science Center at Houston

University of Pennsylvania

Michigan Medicine

Feng Wang is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, hematology, and medicine.

ORCID

Publications per year

2016–2024

15

Publications

15

Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study

Koichi Takahashi, Feng Wang, Hagop M. Kantarjian et al. · The Lancet Oncology · 2016 · 400 citations

, , +13

Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics

Kiyomi Morita, Feng Wang, Katharina Jahn et al. · Nature Communications · 2020 · 387 citations · Full text

, , +17

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia

Kiyomi Morita, Hagop M. Kantarjian, Feng Wang et al. · Journal of Clinical Oncology · 2018 · 183 citations · Full text

, , +14

Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia

Lucille Stuani, Marie Sabatier, Estelle Saland et al. · The Journal of Experimental Medicine · 2021 · 122 citations · Full text

, , +17

AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text

, , +16

1–5 of 15